Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
As of close of business last night, TC BioPharm (Holdings) plc ADR’s stock clocked out at $1.45, down -0.68% from its previous closing price of $1.46. In other words, the price has decreased by -$0.68 from its previous closing price. On the day, 41.34 million shares were traded. TCBP stock price reached its highest trading level at $3.0 during the session, while it also had its lowest trading level at $1.41.
Ratios:
To gain a deeper understanding of TCBP’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.09 and its Current Ratio is at 1.09. In the meantime, Its Debt-to-Equity ratio is 1.16 whereas as Long-Term Debt/Eq ratio is at 0.83.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TCBP now has a Market Capitalization of 4730132 and an Enterprise Value of 91997376. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.39 while its Price-to-Book (P/B) ratio in mrq is 113.10.
Stock Price History:
Over the past 52 weeks, TCBP has reached a high of $22.80, while it has fallen to a 52-week low of $0.85. The 50-Day Moving Average of the stock is -1.50%, while the 200-Day Moving Average is calculated to be -73.83%.
Shares Statistics:
It appears that TCBP traded 4.50M shares on average per day over the past three months and 85470 shares per day over the past ten days. Shares short for TCBP as of 1713139200 were 237548 with a Short Ratio of 0.05, compared to 1710460800 on 638718. Therefore, it implies a Short% of Shares Outstanding of 237548 and a Short% of Float of 7.430000000000001.
